“…Khorana et al reported that in the USA, VTE in a cancer patient entails substantially increased additional hospital costs and more extensive and longer patient care than for a cancer patient without VTE, with average hospital costs 2.9 times higher [9]. In another US study, a general population experiencing VTE was compared with a population without VTE in a real-life setting from 2004 to 2008 [16]. This study showed an annual cost differential per patient, all costs combined, of more than $15,941 (95 % CI, $14,819-$17,012).…”